Skip to product information
1 of 1

IL-34 Protein, Human

IL-34 Protein, Human

Catalog Number: UA040153 Reactivity: Human Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $180.00 USD
Regular price Sale price $180.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Interleukin-34; IL-34;
Accession Q6ZMJ4
Amino Acid Sequence

Asn21-Pro242, with C-terminal His Tag

Expression System CHO
Molecular Weight

30-38 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag His Tag
Physical Appearance Lyophilized Powder
Storage Buffer

20mM Tris, 300mM NaCl, pH8.0

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Science. 2008 May 9;320(5877):807-11.
Nat Immunol. 2012 Jun 24;13(8):753-60.

Background

Interleukin-34 (IL-34) is a cytokine that was discovered in 2008 through functional screening of the extracellular proteome. It shares many functional similarities with colony-stimulating factor 1 (CSF-1), as both can bind to the CSF-1 receptor (CSF-1R) and regulate the differentiation and function of monocytes and macrophages. IL-34 is expressed in various tissues, including the brain, skin, and immune organs, and plays important roles in immune regulation, tissue homeostasis, and inflammation.
The IL-34/CSF-1R axis is a potential therapeutic target for various diseases, including cancer, inflammatory diseases, and autoimmune disorders. Also, IL-34 can serve as a biomarker for certain conditions. For instance, its expression levels in tissues or body fluids may indicate the presence or severity of diseases such as liver fibrosis and diabetic complications.

Picture

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

>95% as determined by RP-HPLC.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)